Background -Obstructive airways disease adversely affects quality of life, although relationships between quality of life and lung function have been shown to be weak. The relationships between the results of a quality of life questionnaire, spirometric tests, and methacholine bronchial challenge were investigated in a population sample of middle aged and elderly people. Obstructive airways disease is common in the elderly, affecting approximately 16% of people over the age of 65.1 It has a substantial impact on quality of life, impairing not only physical, but also psychological and social function.23 The relationship between the degree of quality of life impairment and the severity of airways obstruction as measured by pulmonary function tests has, however, generally been found to be weak.2-5
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Background -Obstructive airways disease adversely affects quality of life, although relationships between quality of life and lung function have been shown to be weak. The relationships between the results of a quality of life questionnaire, spirometric tests, and methacholine bronchial challenge were investigated in a population sample of middle aged and elderly people. Methods -A random population sample of the white population of Central Manchester, UK were contacted by post. Respondents were invited to undergo bronchial challenge with methacholine (Newcastle dosimeter method) and to complete the St George's Respiratory Questionnaire. This self-completed questionnaire quantifies quality of life as three component scores, with higher scores indicating greater impairment of quality of life. Results -Two hundred and twenty seven subjects aged 45-86 years completed the St George's Questionnaire and performed spirometric tests; 190 completed the methacholine challenge. All quality of life scores were higher in subjects with a forced expiratory volume in one second (FEV5)/ forced vital capacity (FVC) of <65%, indicating impaired quality oflife in subjects with airways obstruction. There was no relationship between quality of life and age. Multiple regression analysis showed independent relationships between quality of life scores and both baseline FEVy and bronchial responsiveness. However, the amount of variation in quality of life attributable to variation in FEVy or bronchial responsiveness was less than 10%. Subgroup analysis indicated that the quality-of life score was independently associated with bronchial responsiveness and not FEV1 in subjects aged <65 years, but with baseline FEV, and not bronchial responsiveness in older subjects. Conclusions -Obstructive airways disease significantly impairs quality of life in adults. The reduction in quality of life in these patients is related to both baseline pulmonary function and non-specific bronchial responsiveness. The impact of airways obstruction on quality of life does not decrease with advancing age. Obstructive airways disease is common in the elderly, affecting approximately 16% of people over the age of 65.1 It has a substantial impact on quality of life, impairing not only physical, but also psychological and social function. 23 The relationship between the degree of quality of life impairment and the severity of airways obstruction as measured by pulmonary function tests has, however, generally been found to be weak. [2] [3] [4] [5] It has been suggested that the impact of obstructive airways disease on quality of life may be less in older subjects. 356 We have therefore compared the quality of life in subjects with and without chronic airways obstruction and bronchial hyperresponsiveness to assess the effects of chronic obstructive airways disease and asthma on quality of life in a population sample of adults aged 45-86 years.
Methods
Names of adults aged .45 were taken using random number tables from practice lists of 22 local general practitioners. Those who were confused or housebound were excluded, together with the few unsuitable for other reasons. Non-white subjects were excluded because of interracial differences in bronchial responsiveness. 7 Subjects were sent an explanatory letter and questionnaire concerning previous asthma, bronchitis, ischaemic heart disease, smoking history, and current medication. Non-responders were sent a reminder, followed by a second reminder with an abbreviated questionnaire. A random sample of persistent non of <65% in those aged <65 years; since this ratio decreases with normal ageing, a predicted value and lower limit of normal for FEVI/FVC was calculated for subjects aged .65 using equations from the Cardiovascular Health Study. 16 Bronchial hyperresponsiveness was defined as a PD20 of < 100,g methacholine; this level has been shown to have a predictive value for current asthma of nearly 100%.'7 In all cases significance was defined at the 5% level.
Results
We contacted 783 eligible subjects; 508 returned the full questionnaire and could be assessed for suitability for methacholine challenge. A further 215 subjects completed abbreviated questionnaires (overall response rate 92-3%). Responders were representative of the population in age and sex distribution; those completing full and abbreviated questionnaires were similar in terms of smoking history and prevalence of diagnosed asthma or bronchitis.
One hundred and thirteen subjects were excluded from methacholine challenge because of heart disease or medication; of the 395 invited to attend, 247 agreed. There was a slight age difference between attenders and non-attenders (mean age of attenders 64 5 years, non-attenders 66 1; p=0.02), but attenders were representative in terms ofsmoking habit, diagnosed asthma and bronchitis, and prevalence of respiratory symptoms.
Two hundred and twenty seven attenders performed reproducible spirometric tests and completed the St George's Questionnaire, of whom 26 had a baseline FEV, of <60% predicted, two had electrocardiographic evidence of ischaemic heart disease, and nine were unable to complete the methacholine challenge. Challenge results were thus available for 190 subjects.
One hundred and twenty eight of the 227 subjects who performed spirometric tests were women. The age distribution is shown in fig 1 . Seventy one subjects were current smokers and 91 were ex-smokers. Thirty three reported a previous diagnosis of asthma and 52 "bronchitis"; 33 were using inhaled bronchodilators and/or an inhaled steroid. Figure 2 shows the distribution of baseline FEV,. life scores were similar for men and women. There was no correlation between quality of life scores and age. However, the mean Activities score was significantly higher for subjects aged .65 years (geometric mean (SD) 1-04 (0-71)) than for those aged <65 years (0-81 (0-76); t= -2-34, p=0 02).
Total quality of life scores were significantly higher in the 59 subjects with chronic airways obstruction, indicating quality of life impairment in subjects with obstructive airways disease. Similarly, all quality of life scores except the Impacts score were significantly higher in those with bronchial hyperresponsiveness (table 1) .
For the whole group there was significant negative correlation between log total quality of life score and baseline FEV, (expressed as standardised residuals) (r=-0 47, p<0 001; fig 4) . There was also a significant positive correlation between log total quality of life score and log dose-response slope (r=0'20, p<0 005; fig 5) . Similar correlations were seen between baseline FEV, (standardised residuals) and log Activities score (r= -0 38, p<0 001), log Impacts score (r= -047, p<0 001) and log Symptoms score (r=-037, p<0 001), and between the log dose-response slope and log Activities score (r= 0-18, p<0 0 1), log Impacts score (r=0-17, p<001), and log Symptoms score (r=0-23, p=0.001). The St George's Questionnaire is a diseasespecific quality of life score designed for use in subjects with airways obstruction. As such, it has not been validated in a general population sample. In the current study subjects with no airways disease tended to record very low quality of life impairment, particularly for the Symptoms score. This produced a skewed distribution of quality of life scores. St George's Questionnaire scores have been shown to be independent of age in subjects aged up to 75 years,8 but the questionnaire has not been validated in older subjects. The lack of correlation between quality of life scores and age in the current study suggests that the questionnaire is also valid in the elderly. However, the mean Activities score was higher for older subjects, indicating reduced activity levels with age.
Interestingly, where other studies have shown a change in quality of life with increasing age in subjects with asthma or obstructive airways disease, this has generally been an improvement in quality of life in older subjects.3`6 This has led to the suggestion that older subjects may be more tolerant of the effects of airways obstruction due to a reduction in their normal activity levels or in their expectations of life. It has been shown that older adults describe less severe symptoms than younger adults when exposed to the same degree of methacholineinduced bronchoconstriction.22 However, there is no evidence for a general decrease in the reporting ofdistressing symptoms by the elderly -indeed the opposite may be true. 23 The results of the current study do not confirm a reduction in the impact of obstructive airways disease on quality of life in older people.
Our results show that the interrelationships between bronchial responsiveness, baseline FEVI, and quality of life scores change with age. The reasons for this are not clear. Mortagy et al have described a cluster of respiratory symptoms representing "bronchial irritability" which are associated with increased bronchial responsiveness in young adults.24 However, the predictive value of these symptoms for increased bronchial responsiveness is much lower in the elderly.' Since respiratory symptoms affect quality of life, the lack of "bronchial irritability" symptoms in older adults with increased bronchial responsiveness may reduce the strength of the relationship between bronchial responsiveness and quality of life in this age group. Alternatively, our results may reflect a change in the interaction between baseline FEV, and bronchial responsiveness with age, rather than a change in their interaction with quality of life.
Schrier et al have also shown that obstructive airways disease is associated with impairment of quality of life in adults over a wide age range.' However, it is not clear whether quality of life was related to age in this study. The influence of increased bronchial responsiveness on quality of life was studied in young asthmatics by Malo et al29 who found the mean quality of life score to be weakly but significantly correlated with baseline FEV, and non-specific bronchial responsiveness, as in the current study.
